The browser version you are using is not recommended for this site.Please consider upgrading to the latest version of your browser by clicking one of the following links.
At OHSU’s Knight Cancer Institute, matching the right therapy to a cancer requires tremendous amounts of computing power, and Intel is helping enable greater genomic understanding with new tools and architectures to speed the discovery.
Researchers discuss next-gen genome sequencing on the Intel® Xeon® processor E5-2600 v3 product family.
Ward efficiency boosts on Intel®-based tablets, providing doctors convenient workstation apps in-hand.
Discussing the importance of bringing an enterprise-ready big data platform to the mainstream.
Genome data analysis realizes a competitive advantage for the collation of Big Data with cost-effective scalability
Jenna Hartley wants to help people through medical research, like those with CF-related infections.
A 2 in 1 device costs less than a tablet and laptop for support, software, IT, and security.